Skip to content
OpenCapital
Get started

Rogers Corporation ROG EPS (Basic)

EPS (Basic) at other companies

3M logo
3MMMM
$1.23-40.0%
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
-$1.18-45.7%
Biogen logo
BiogenBIIB
$2.17+31.5%
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
$0.26+52.9%
DuPont de Nemours, Inc. logo
DuPont de Nemours, Inc.DD
$0.39+128%
Chemours logo
ChemoursCC
-$0.19-533%

Other financials

Income statement

See full
Revenue$200.5M+5.2%
Gross profit$64.6M+13.3%
Operating income$10.7M+3,667%
Net income$4.5M+421%
EPS (diluted)$0.25+413%

Balance sheet

See full
Cash & equivalents$195.8M+11.5%
Total debt$29.8M-10.5%
Total equity$1.2B-6.1%
Total assets$1.4B-5.6%

Cash flow

See full
Operating cash flow$5.8M-50.4%
CapEx$4.7M-51.0%
Free cash flow$1.1M-47.6%

Valuation

See full
Market cap$2.84B+53.1%
Enterprise value$2.67B+57.7%
P/S3.5×+1.2×

Profitability

See full
Gross margin32.2%-0.7pp
Operating margin8.1%-6.7pp
Net margin-7.4%-9.5pp
FCF margin8.5%+1.8pp

Returns & leverage

See full
Return on equity-4.9%-6.3pp
Debt / equity0×0.0×
Current ratio4×+0.1×

Where this comes from

Reported directly by Rogers Corporation in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareBasic.

The official record: Rogers Corporation’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rogers Corporation's eps (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Rogers Corporation's EPS (basic)?
Rogers Corporation (ROG) reported EPS (basic) of $0.25 in Q1 2026.
How has Rogers Corporation's EPS (basic) changed year-over-year?
Rogers Corporation's EPS (basic) increased by 412.5% year-over-year, from -$0.08 to $0.25.
What is the long-term trend for Rogers Corporation's EPS (basic)?
Over 4 years (2021 to 2025), Rogers Corporation's EPS (basic) has grown at a -11.1% compound annual growth rate (CAGR), from $5.77 to -$3.60.
What does EPS (basic) mean?
Net income available to common shareholders divided by the weighted-average number of common shares outstanding during the period. Does not account for dilutive securities.